Kidney patients needed to test drug safety
NCT ID NCT06723535
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the drug BMS-986278 behaves in people with normal kidneys, severe kidney disease, or kidney failure on dialysis. 27 adults took a single dose to measure drug levels and check for side effects. The goal was to gather safety information, not to treat the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Local Institution - 0002
Miami, Florida, 33147-4040, United States
-
Local Institution - 0003
Miami, Florida, 33172, United States
-
Local Institution - 0004
Orlando, Florida, 32808-7820, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809-3017, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Can a new drug work safely in patients with kidney failure?
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?